Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder

NCT01939353 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult ADHD

Interventions

DRUG: CTN SR
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.